"/> Novus Biologicals™ Peptide bloquant d’anticorps IR… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps IRF4

Réf. : BL-RE-142674Réf. fabricant : 18240396 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
3662
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-76574. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 16 amino acids near the carboxy terminus of human IRF4.

Points forts

Source

Synthetic

(Accession #: NP_002451) The IRF4 Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-142674
Réf. fabricant18240396
Gene ID (Entrez)3662
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-76574. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gèneinterferon regulatory factor 4, IRF-4, LSIRFMUM1, Lymphocyte-specific interferon regulatory factor, Multiple myeloma oncogene 1, NF-EM5
Symbole de gène(s)IRF4
Type de produitIRF4
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne16 amino acids near the carboxy terminus of human IRF4
Une question, une configuration particulière ?
Contactez-nous pour un devis.